Nuwellis, Inc.
NUWE Nasdaq· Electromedical & Electrotherapeutic Apparatus
Last close · Oct 27, 2026
$5.41
KIRA · Stoqly’s AI analyst, in plain words
- Nuwellis, Inc. had $8.3M of revenue in fiscal 2025, down 5.4% on the year before. Over five years, revenue changed +2.1% a year on average.
- Its operating margin was −134.3%, down 8.6 pts: of every 100 in sales, about −134 is left after running the business.
- Nuwellis, Inc. lost $17.5M in fiscal 2025.
- Free cash flow was −$10.9M in fiscal 2025, −131.8% of revenue.
Market cap
$1.0M
P/E
0.0x
Revenue
$8.3M
Net income
−$17.5M
Free cash flow
−$10.9M
Operating margin
−134.3%
Nuwellis, Inc. in 30 seconds · fiscal 2025
Are sales growing?
−5.4%
No. Sales fell 5.4% last year.
Does it make a profit?
−211.9%
No. It lost money last year.
Does profit turn into cash?
−131.8%
No. It spent more cash than it brought in.
How healthy are the accounts?
2 / 8
Weak. It passes 2 of 8 health tests.
How is the share priced?
0.0x
One share costs 0.0 times its yearly profit per share.
What Nuwellis, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 11, 2026
- Legal name
- Nuwellis, Inc.
- CIK
- 0001506492
Nuwellis, Inc. · NUWE
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $7.9M | $8.5M | $8.9M | $8.7M | $8.3M |
| Revenue growth | 6.5% | 7.9% | 3.8% | −1.4% | −5.4% |
| Gross margin | 56.7% | 55.7% | 56.2% | 64.9% | 62.0% |
| Operating margin | −246.5% | −201.0% | −198.9% | −125.7% | −134.3% |
| Net income | −$19.6M | −$14.5M | −$20.2M | −$11.2M | −$17.5M |
| Net margin | −246.9% | −170.0% | −228.0% | −127.7% | −211.9% |
| Diluted EPS | −$285.36 | −$83.55 | −$360.06 | −$353.30 | −$25.39 |
| Cash | |||||
| Cash from operations | −$17.8M | −$15.1M | −$17.9M | −$9.6M | −$10.8M |
| Capital expenditure | $0.2M | $0.1M | $0.1M | $0.1M | $0.1M |
| Free cash flow | −$18.1M | −$15.3M | −$18.1M | −$9.7M | −$10.9M |
| FCF margin | −228.0% | −178.8% | −204.0% | −110.4% | −131.8% |
| Share count change | −95.8% | 151.9% | −67.7% | −43.7% | 2,083.9% |
| Debt and strength | |||||
| Cash and short-term investments | $24.2M | $18.3M | $3.8M | $5.1M | $1.1M |
| Shareholders' equity | $25.9M | $12.4M | $3.0M | $6.5M | $2.6M |
| Current ratio | 8.5x | 4.9x | 2.6x | 3.5x | 1.7x |
| Returns and quality | |||||
| Return on equity | −92.5% | −75.8% | −263.4% | −234.6% | −382.9% |
| Return on tangible equity | −75.6% | −117.5% | −756.8% | −162.7% | −667.6% |
| Piotroski F-score | 5 | 2 | 4 | 5 | 2 |
| Altman Z'' | −20.0 | −34.1 | −104.2 | −100.0 | −177.6 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Nuwellis, Inc. · NUWE
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $5.41 a share, the company is worth $1.0M: 0.0 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0001506492). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.